Altasciences Develops a Quantitative Serological Assay for the Detection of SARS-CoV-2 IgG Antibodies

Altasciences in partnership with a number of not-for-profit organizations, is developing a quantitative serological assay for the detection of SARS-CoV-2 IgG antibodies. Using several different antigens to enable solutions, our partnerships will alleviate the supply and quality of reagents in order to support vaccine development.

We have the experience and know-how to support your preclinical and clinical vaccine development programs.

Contact us today